...
机译:Neoadjuvant经截面动脉化疗组合和原位肝移植治疗肝硬化肝细胞癌
Hosp Univ Penn Penn Image Guided Intervent Lab 3400 Spruce St Philadelphia PA 19104 USA;
Hosp Univ Penn Dept Radiol 3400 Spruce St Philadelphia PA 19104 USA;
Hosp Univ Penn Dept Pathol 3400 Spruce St Philadelphia PA 19104 USA;
Hosp Univ Penn Dept Surg Div Transplant Surg 3400 Spruce St Philadelphia PA 19104 USA;
Hosp Univ Penn Penn Image Guided Intervent Lab 3400 Spruce St Philadelphia PA 19104 USA;
Hosp Univ Penn Penn Image Guided Intervent Lab 3400 Spruce St Philadelphia PA 19104 USA;
Hosp Univ Penn Dept Radiol 3400 Spruce St Philadelphia PA 19104 USA;
Hosp Univ Penn Dept Pathol 3400 Spruce St Philadelphia PA 19104 USA;
Hosp Univ Penn Dept Surg Div Transplant Surg 3400 Spruce St Philadelphia PA 19104 USA;
Hosp Univ Penn Penn Image Guided Intervent Lab 3400 Spruce St Philadelphia PA 19104 USA;
机译:Neoadjuvant经截面动脉化疗组合和原位肝移植治疗肝硬化肝细胞癌
机译:原位肝移植术后复发性不可切除肝细胞癌的经导管动脉化疗栓塞
机译:肝细胞癌患者的经导管动脉化学栓塞术在原位肝移植的等待名单上。
机译:慢病毒结合射频消融联合经导管动脉化疗栓塞治疗肝细胞癌
机译:倍半萜类药物可作为肝细胞癌(HCC)的潜在治疗方法:在大鼠HCC肿瘤模型中,通过经动脉化学栓塞术施用的小白菊内酯的临床前评估。
机译:经肝动脉严重栓塞治疗并经肝动脉根治性肝移植成功治疗肝癌
机译:具有顺铂的经变性动脉灌注化疗与经截面动脉化疗栓塞组合降低了不可切除的肝细胞癌的肝内远程复发